Publications by authors named "Jamie M Davis"

Claim this Profile
4
4-Alkyl and 4,4'-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis.
Kristina M K Kutterer, Jamie M Davis, Guy Singh, Youjun Yang, William Hu

Bioorg Med Chem Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.
Aranapakam M Venkatesan, Jamie M Davis, George T Grosu, Jannie Baker, Arie Zask

J Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.
Venkatesan Aranapakam, George T Grosu, Jamie M Davis, Baihua Hu, John Ellingboe

J Med Chem· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.
Venkatesan Aranapakam, Jamie M Davis, George T Grosu, Jannie Baker, John Ellingboe

J Med Chem· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis